Measles IgG sero-prevalence and its attributable factors in 5–25-year-old cases prior mass vaccination campaign in Urmia, northeastern Iran

AUTHORS

Z Yekta 1 , * , R Porali 2 , MR Taravati 3 , Sh Salary 4 , F Khalily 3 , S Shahabi 3

1 Department of Community Medicine Urmia University of Medical Sciences, Urmia, azarbaijan, Iran

2 Department of Health Education Urmia University of Medical Sciences, Urmia, azarbaijan, iran

3 Department of Immunology,Faculty of Medicine,Urmia University of Medical Sciences, Urmia, azarbaijan, Iran

4 Department of Community Medicine Urmia University of Medical Sciences, Urmia, azarbaijan, iran

How to Cite: Yekta Z, Porali R, Taravati M, Salary S, Khalily F, et al. Measles IgG sero-prevalence and its attributable factors in 5–25-year-old cases prior mass vaccination campaign in Urmia, northeastern Iran, Iran Red Crescent Med J. 2007 ; 9(1):e95867.

ARTICLE INFORMATION

Iranian Red Crescent Medical Journal: 9 (1); e95867
Published Online: January 31, 2007
Article Type: Research Article
Received: July 01, 2019
Accepted: January 31, 2007

Crossmark

CHEKING

READ FULL TEXT
Abstract

Background: Measles is a vaccine preventable infectious disease. Despite the widespread availability of an effective measles vaccine, the number of measles cases is noticeable in Iran. Because measles –specific antibody titer after vaccination is lower than after natural infection there is a concern that vaccinated persons may gradually lose protection from measles. This study was performed to examine the persistence of vaccine-induced antibody, participants with documented history of vaccination were assessed to determine the sero-prevalence and titer of measles antibody.

 

Methods: This study was carried out in Urmia. Iran. Documented history of at least a single dose of live attenuated measles vaccine (at 9 or 15 month of age) was the inclusion criteria. Blood was collected from 835 subjects between 5 and 25 years old. The sera were tested for anti-measles IgG antibodies, by ELISA (IBL Germany). Associations between predictive factors such as demographic data, vaccination status (once or twice) with IgG sero prevalence in routine vaccinated subjects were investigated by logistic regression analysis.

 

Results: The antibody titers in 54.76% of cases were in the range of protective level (IgG>12IU). The mean of antibody titer significantly increased after the 16th year of life. The antibody titers were higher in participants who received one dose of measles vaccine in comparison with the persons who received a booster of measles vaccine. Antibody titers were slightly higher in men than in women. On multiple logistic regression analysis, of all variables examined, only vaccination status retained a significant association with antimeasles sero-positivity rate (estimated odds ratio = 0.395 95% CI = 0.214-0.859, P<0.05).

 

Conclusion: Elevation of antibody titer many years after vaccination is most likely due to boosting effect from repeated exposure to circulating wild virus resulting in unapparent or sub-clinical re-infection. This group of persons would be the most likely to support viral transmission in the absence of disease.

Keywords

Measles Immunization Antibody Sero-positivity

© 2007, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.

Fulltext

This part is available in the PDF file.

References

  • 1.

    The references are available in the PDF file.

  • COMMENTS

    LEAVE A COMMENT HERE: